RIL
Rothschild Investment LLC Portfolio holdings
AUM
$1.6B
1-Year Return
17.99%
This Quarter Return
+8.91%
1 Year Return
+17.99%
3 Year Return
+73.94%
5 Year Return
+135.61%
10 Year Return
+254.21%
AUM
$919M
AUM Growth
+$88M
(+11%)
Cap. Flow
+$26M
Cap. Flow
% of AUM
2.83%
Top 10 Holdings %
Top 10 Hldgs %
21.81%
Holding
470
New
41
Increased
182
Reduced
124
Closed
34
Top Buys
| 1 |
DraftKings
DKNG
|
$9.6M |
| 2 |
Invitation Homes
INVH
|
$7.25M |
| 3 |
Invesco FTSE RAFI Emerging Markets ETF
PXH
|
$2.02M |
| 4 |
Applied Materials
AMAT
|
$1.74M |
| 5 |
AT&T
T
|
$1.39M |
Top Sells
| 1 |
United Parcel Service
UPS
|
$11.2M |
| 2 |
Canadian Pacific Kansas City
CP
|
$7.21M |
| 3 |
Apple
AAPL
|
$2.59M |
| 4 |
Thermo Fisher Scientific
TMO
|
$2.17M |
| 5 |
Target
TGT
|
$1.83M |
Sector Composition
| 1 | Healthcare | 16.2% |
| 2 | Technology | 15.61% |
| 3 | Financials | 9.68% |
| 4 | Industrials | 8.7% |
| 5 | Consumer Discretionary | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Wells Fargo
WFC
$253B
| $598K | 0.07% |
25,455
-2,966
| -10% | -$69.7K |
|
202
Air Products & Chemicals
APD
$64.5B
| $596K | 0.06% |
2,000
| – | – |
|
203
Charter Communications
CHTR
$35.7B
| $596K | 0.06% |
954
| – | – |
|
204
Takeda Pharmaceutical
TAK
$48.6B
| $587K | 0.06% |
32,904
+779
| +2% | +$13.9K |
|
|
ATH
205
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $583K | 0.06% |
17,111
+5,347
| +45% | +$182K |
|
206
Technology Select Sector SPDR Fund
XLK
$84.1B
| $582K | 0.06% |
4,985
-100
| -2% | -$11.7K |
|
207
Zebra Technologies
ZBRA
$16B
| $577K | 0.06% |
2,286
+731
| +47% | +$185K |
|
208
PNC Financial Services
PNC
$80.5B
| $573K | 0.06% |
5,217
+110
| +2% | +$12.1K |
|
209
Hanesbrands
HBI
$2.27B
| $566K | 0.06% |
35,948
-2,400
| -6% | -$37.8K |
|
210
T Rowe Price
TROW
$23.8B
| $564K | 0.06% |
4,398
-75
| -2% | -$9.62K |
|
211
Vanguard S&P 500 ETF
VOO
$728B
| $554K | 0.06% |
1,801
+25
| +1% | +$7.69K |
|
212
Signet Jewelers
SIG
$3.85B
| $548K | 0.06% |
29,325
| – | – |
|
213
Pacira BioSciences
PCRX
$1.19B
| $541K | 0.06% |
8,998
+939
| +12% | +$56.5K |
|
214
Equinix
EQIX
$75.7B
| $534K | 0.06% |
703
| – | – |
|
215
CME Group
CME
$94.4B
| $528K | 0.06% |
3,153
-65
| -2% | -$10.9K |
|
216
Mondelez International
MDLZ
$79.9B
| $528K | 0.06% |
9,189
+100
| +1% | +$5.75K |
|
217
Pitney Bowes
PBI
$2.11B
| $527K | 0.06% |
99,269
-3,000
| -3% | -$15.9K |
|
218
Comcast
CMCSA
$125B
| $508K | 0.06% |
10,980
-3,363
| -23% | -$156K |
|
219
Gilead Sciences
GILD
$143B
| $503K | 0.05% |
7,961
| – | – |
|
220
Dollar Tree
DLTR
$20.6B
| $502K | 0.05% |
5,494
-875
| -14% | -$80K |
|
221
Medical Properties Trust
MPW
$2.77B
| $494K | 0.05% |
28,000
| – | – |
|
222
Electronic Arts
EA
$42.2B
| $487K | 0.05% |
3,735
+955
| +34% | +$125K |
|
223
Intuitive Surgical
ISRG
$167B
| $486K | 0.05% |
2,055
+105
| +5% | +$24.8K |
|
224
DuPont de Nemours
DD
$32.6B
| $484K | 0.05% |
8,723
+282
| +3% | +$15.6K |
|
225
Colgate-Palmolive
CL
$68.8B
| $482K | 0.05% |
6,254
+2,668
| +74% | +$206K |
|